PVAM
SAGE

Pacific View Asset Management’s Sage Therapeutics SAGE Stock Holding History

Pacific View Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,307
Closed -$971K – 32
2019
Q2 		$971K Sell
5,307
-28,023
-84% -$4.78M 1.05% 25
2019
Q1 		$5.3M Buy
33,330
+29,896
+871% +$4.33M 5.51% 4
2018
Q4 		$329K Sell
3,434
-4,974
-59% -$569K 0.39% 42
2018
Q3 		$1.19M Sell
8,408
-26,766
-76% -$4.13M 0.94% 23
2018
Q2 		$5.5M Buy
35,174
+13,697
+64% +$2.15M 4.36% 4
2018
Q1 		$3.46M Buy
21,477
+15,046
+234% +$2.55M 2.61% 9
2017
Q4 		$1.06M Buy
+6,431
New +$623K 0.7% 34

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Pacific View Asset Management's SAGE Position: Q3 2019 in Review

Pacific View Asset Management sold out of Sage Therapeutics (SAGE) in Q3 2019, closing a stake of 5,307 shares — an estimated $971K sold.

Pacific View Asset Management first reported a position in SAGE in Q4 2017 and held it in 7 quarters. The position peaked at $5.5M in Q2 2018. 284 funds tracked by Wall St. Rank hold SAGE as of Q3 2019.

  • Pacific View Asset Management reported no remaining Sage Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Pacific View Asset Management sold 5,307 Sage Therapeutics shares in Q3 2019, an estimated $971K.
  • Pacific View Asset Management first reported a position in Sage Therapeutics in Q4 2017 and held it in 7 quarters.
  • Pacific View Asset Management's Sage Therapeutics position peaked at $5.5M in Q2 2018.
  • 284 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2019.

Based on Pacific View Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.